1. Home
  2. MUX vs NVAX Comparison

MUX vs NVAX Comparison

Compare MUX & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

HOLD

Current Price

$19.45

Market Cap

1.6B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.34

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUX
NVAX
Founded
1979
1987
Country
Canada
United States
Employees
1432
N/A
Industry
Precious Metals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
MUX
NVAX
Price
$19.45
$9.34
Analyst Decision
Strong Buy
Hold
Analyst Count
4
9
Target Price
$26.63
$11.33
AVG Volume (30 Days)
1.0M
4.4M
Earning Date
03-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
N/A
$1,123,479,000.00
Revenue This Year
$22.52
N/A
Revenue Next Year
$26.24
N/A
P/E Ratio
N/A
$3.62
Revenue Growth
N/A
64.69
52 Week Low
$6.38
$5.01
52 Week High
$29.70
$11.85

Technical Indicators

Market Signals
Indicator
MUX
NVAX
Relative Strength Index (RSI) 34.24 45.42
Support Level $17.70 $9.14
Resistance Level $20.59 $10.42
Average True Range (ATR) 1.31 0.54
MACD -0.62 -0.18
Stochastic Oscillator 15.48 4.92

Price Performance

Historical Comparison
MUX
NVAX

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: